NR 508 Week 6 Inhaled Steroid Failure Analysis Example

Course	NR 508 Advanced Pharmacology
Week	6
Paper type	Therapeutic failure write-up
Length	About 1,160 words, 3 pages
Format	APA 7 student paper
School	Chamberlain University
Program	MSN
Updated	October 2026

Free sample paper for NR 508 Week 6

Still Wheezing on Fluticasone 440 mcg a Day: Five Places an Inhaled Steroid Can Fail for a 34-Year-Old Line Cook, Ranked From Four Refills a Year to the Albuterol Count That May Be Measuring the Wrong Thing

Student Name

College of Nursing, Chamberlain University

NR 508: Advanced Pharmacology

Instructor Name

Month Day, Year

What this page is doingThe title presents a ranked set of explanations rather than a single verdict, which is the point of a therapeutic failure analysis. Student APA 7 title page.

The Failure

Mr. J., 34, a line cook, has had asthma since childhood. A year ago his clinician started fluticasone propionate HFA 110 mcg, two puffs twice daily, 440 mcg a day, with albuterol as needed. He reports that his asthma is no better: he uses albuterol five or six times a week, wakes with cough and wheeze two nights a week, and feels tight during long shifts in a hot kitchen. His clinician is considering stepping up to a combination inhaler with a long-acting bronchodilator.

Before adding a drug, the question is why the first one appears to have failed. This paper places each possible explanation at a point the molecule must pass, from getting into the airway to the way success is being measured, ranks them, and says what would tell them apart.

1. It Never Got In

The first place a drug can fail is before it reaches its target. For an inhaled steroid that means two things: the inhaler has to be used, and the dose has to reach the lower airways. Mr. J.'s pharmacy record shows four fluticasone inhalers dispensed in twelve months. Each inhaler contains 120 actuations, which at four puffs a day lasts 30 days, so he collected about a third of the prescribed doses. Adherence at that level matters: in one large study, reductions in exacerbations were statistically significant only when patients took more than 75% of their prescribed inhaled corticosteroid dose, and an estimated 24% of exacerbations were attributable to nonadherence (Williams et al., 2011).

Technique is the second part. Watching him use the inhaler in clinic, he takes a fast breath, presses the canister at the end of it and uses no spacer. Much of each dose then lands in his mouth and throat rather than his airways. What would confirm this explanation: a correct demonstration with a spacer, a month of daily use tracked by counting doses, and a measurable improvement.

Rank: first. It is common, it is directly measurable from records he already has, and both halves of it are present.

What this page is doingEach explanation is placed at a point in the drug's path and paired with what would confirm or exclude it.

2. The Target Has Changed

Inhaled corticosteroids work by suppressing eosinophilic airway inflammation, and some patients respond less because the inflammation is different or less steroid-sensitive. Mr. J. smokes about half a pack a day. Cigarette smoking reduces the response to inhaled steroids: in a randomized trial in mild asthma, nonsmokers given fluticasone improved their morning peak flow by 27 L/min, while smokers showed no significant improvement in peak flow, lung function, airway responsiveness or sputum eosinophils (Chalmers et al., 2002).

What would confirm this explanation: persistent symptoms despite proven adherence and good technique, with continued smoking; improvement after quitting would support it. Rank: second. It is present and has good evidence, but it can only be judged once the first explanation has been dealt with, because a smoker who takes a third of his doses badly would do poorly regardless.

3. The Measure Is Wrong

The judgment that fluticasone has failed rests largely on his albuterol use. But when asked, Mr. J. says he takes two puffs of albuterol before most shifts "to be safe," whether or not he has symptoms, because the kitchen gets hot. Four or five of his weekly doses may be routine, not responses to symptoms. If so, his albuterol count overstates his loss of control.

What would separate this explanation: a two-week diary recording each albuterol use and whether it was for symptoms or routine, a validated control questionnaire such as the Asthma Control Test, and spirometry. Rank: third. It is real and easily checked, and it could change the conclusion, but his night waking is harder to explain this way.

4. It Was Never the Problem

Some of what looks like uncontrolled asthma is not asthma. Tightness in a hot kitchen could be exercise- or heat-related bronchoconstriction, which is still asthma, but it could also be inducible laryngeal obstruction, sometimes called vocal cord dysfunction, which causes throat tightness and noisy breathing that do not respond to steroids. Night cough can come from gastroesophageal reflux. Kitchen fumes and smoke can cause an occupational irritant response.

What would separate these: whether his symptoms are felt in the throat or the chest, whether they improve on days off, flow-volume loops during symptoms, and a reflux history. Rank: fourth. None of these is suggested strongly by the history so far, and each needs a specific test, but they should be considered if the first three are addressed and he remains symptomatic.

5. It Left Too Quickly

For a systemic drug, rapid clearance, for example from an interacting drug that induces its metabolism, is a common cause of failure. For an inhaled steroid acting locally in the airway, this is much less relevant, and Mr. J. takes no other medicines. Rank: last. Naming it and placing it last is useful, because it shows the question was asked rather than overlooked.

Defending the Order

The order follows two rules: put first what is most common and most easily confirmed, and put first what must be fixed before the others can be judged. Adherence and technique come first on both counts. Smoking comes second because its effect can only be judged in someone taking the drug properly. The measurement question comes third because it could show that his control is better than it looks, which would change the decision about stepping up. Alternative diagnoses come fourth because they need specific tests. Rapid clearance comes last because it barely applies.

The practical conclusion is that stepping up to a combination inhaler now would add a second drug to a first that has not yet been tested. The first steps are a spacer and technique teaching, a plan to track adherence, help with quitting smoking, and a two-week symptom diary, with review in four to six weeks. If he is still uncontrolled then, stepping up is justified, and the ranking will have done its job.

There is also a cost to getting the order wrong. A combination inhaler added now would probably be used as irregularly as the first, would cost him more at the pharmacy, and would add a second drug whose apparent failure would later be just as hard to interpret. Worse, if his control then improved because a new inhaler prompted better use, the credit would go to the long-acting bronchodilator rather than to the adherence that actually changed.

References

Chalmers, G. W., Macleod, K. J., Little, S. A., Thomson, L. J., McSharry, C. P., & Thomson, N. C. (2002). Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax, 57(3), 226-230. https://doi.org/10.1136/thorax.57.3.226

Williams, L. K., Peterson, E. L., Wells, K., Ahmedani, B. K., Kumar, R., Burchard, E. G., Chowdhry, V. K., Favro, D., Lanfear, D. E., & Pladevall, M. (2011). Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. Journal of Allergy and Clinical Immunology, 128(6), 1185-1191. https://doi.org/10.1016/j.jaci.2011.09.011

The Chamberlain NR 508 Week 6 instructions

The Week 6 write-up asks you to analyze a case of therapeutic failure. You will likely need the case, possible explanations, how each could be confirmed or excluded, a ranking with justification, a recommended next step and APA. Before adding a drug, ask why the first one appears to have failed. Place each explanation at a point in the drug's path: getting in, reaching the target, being measured, being the right problem and being cleared. Pair each with the evidence that would separate it from the others. Rank them by how common and how easily confirmed they are, and by what must be fixed first. State the cost of getting the order wrong.

How the NR 508 Week 6 example is put together

The failure section describes Mr. J.'s childhood asthma, a year on fluticasone 110 mcg two puffs twice daily and continued frequent albuterol use. The first explanation uses pharmacy records showing about four refills a year and technique observed in clinic, citing Williams and colleagues on adherence. The second explains that inhaled steroids suppress eosinophilic inflammation and that smoking reduces response. The third reveals that he uses albuterol before most shifts out of habit. The fourth considers heat-related bronchoconstriction or upper airway causes. The fifth notes that rapid clearance matters little for inhaled steroids. The order section defends two rules for ranking. The conclusion argues that a combination inhaler now would add a second drug to an untested first.

NR 508 Week 6 rubric: what full points look like

Therapeutic failure rubrics in NR 508 generally weigh identification of possible causes, a mechanism for each, evidence that would distinguish them, a justified ranking, a sound recommendation and APA. Distinguishing evidence is the row that sets this paper apart, since each explanation is paired with a test. Causes are credited for following the drug's path. Ranking scores because two explicit rules decide the order. The recommendation earns points for fixing adherence and technique before adding a drug. The cost of a wrong order is credited as practical reasoning. Chalmers and colleagues and Williams and colleagues support it. Using pharmacy refill data as evidence shows the explanations can be tested.

NR 508 Week 6 help from the desk

Points go first where the write-up offers explanations it cannot tell apart, presenting them as equals with no test to separate them. Another loss is assuming the drug failed without checking whether it was taken or measured correctly. Students also add a new drug before fixing technique, skip nonpharmacologic causes or rank without reasons. Three to five explanations are typical. Doses that were never taken are one of the most important explanations. The write-up does not have to reach one answer, but it should rank them. Send your case and an NR 508 failure analysis can place each explanation on the drug's path. Pair every explanation with a way to confirm it.

Get a NR 508 Week 6 example written to your instructions

Send the Week 6 case and instructions, including any cap on the number of explanations, and a custom example is written to that case and returned inside 24 to 48 hours, the first one free. Where your section supplies laboratory results or a fill history with the case, include those too, because they are what the ranking is built on.

More NR 508 papers and MSN samples

NR 508 Week 6 questions, answered

How many explanations should the write-up carry?

Follow the instructions where they set a number. Where they do not, four or five worked properly beats eight listed, because every candidate has to arrive with the finding that would confirm or drop it and that is what consumes the length. A candidate with nothing attached to it adds no marks and dilutes the ones that were argued.

Can doses that were never taken be one of the explanations?

Yes, and it belongs in the ranking like any other, with its own evidence rather than as a closing shrug. What separates a strong treatment of it is that it is checkable: fill dates, an untouched supply, a level that never rose. Treated that way it is a pharmacologic finding. Asserted about the person, it ends the reasoning early and the marks with it.

Does the write-up have to reach one answer?

Almost never, and reaching for one usually costs points. Sections that set this task are marking the ordering and the discrimination between neighboring candidates, so a defended ranking that ends on what would be checked next is the stronger document. Commit only where the case actually contains the finding that settles it, and say which finding that was.

Where can I find a free NR 508 Week 6 sample paper?

Every part of the Week 6 analysis of inhaled steroid failure, with five ranked explanations, their tests, the order defended, the recommendation and two references.

What is ranked first in the NR 508 Week 6 write-up?

That the drug never got in: pharmacy records show about four refills a year, and his technique delivers little to the lungs, so adherence and technique must be fixed first.